Coronavirus | EU drug regulator evaluating Pfizer vaccine for youngsters in 12-15 age group
The Hindu
European Medicines Agency evaluating request by Pfizer Inc and BioNTech
The European Union's drug regulator said Monday it has begun evaluating aInc and BioNTech to extend approval of their coronavirus vaccine to include children ranging in age from 12 to 15. The European Medicines Agency's human medicines committee will carry out an accelerated assessment of data submitted by Pfizer and BioNTech and is expected to reach a decision in June, unless it requires extra information, the agency said. In a statement Friday, the two pharmaceuticals said their request is based on an advanced study in more than 2,000 adolescents that showed their vaccine to be safe and effective. The children will continue to be monitored for longer-term protection and safety for another two years.More Related News
The event will run daily from 10 a.m. to 8.30 p.m., offering a variety of activities. Visitors can enjoy dance and music performances, hands-on art experiences, film screenings, and exhibitions from 10.30 a.m. to 6.30 p.m. These will feature folk cuisines, leather puppets, philately, textiles, and handicrafts.